Tilray Brands Inc. Class 2 (TLRY) Peer Comparison
$4.59
$0.02
(0.44%)
As on 28-Aug-2026 16:25EDT
Market cap
$666 Mln
Revenue (TTM)
$1,156 Mln
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Edit
| Tilray Brands Inc. Class 2 (TLRY) | Lexaria Bioscience (LEXX) | Cardinal Health (CAH) | |
|---|---|---|---|
Market cap ($ Mln) |
666 | 18 | 53,134 |
Revenue ($ Mln) |
915 | 0 | 254,248 |
Net Profit ($ Mln) |
-122.57 | -7.73 | 1,714.00 |
Net Margin (%) |
-12.90 | -3,985.58 | 0.67 |
RoE (%) |
-6.65 | -160.06 | -60.52 |
Price to Earnings |
-- | -- | 32.45 |
Price-To-Book |
0.41 | 4.00 | 16.07 |
Income Statement ($ Mln)
| Tilray Brands Inc. Class 2 (TLRY) | Lexaria Bioscience (LEXX) | Cardinal Health (CAH) | |
|---|---|---|---|
|
Operating Revenue
|
915.45 | -- | 254,248.00 |
|
Cost of Revenue
|
655.01 | -- | 244,474.00 |
|
Gross Profit
|
260.44 | -- | 9,774.00 |
|
Operating Expenses
|
323.47 | -- | 7,161.00 |
|
Operating Profit (EBIT)
|
-63.03 | -- | 2,613.00 |
|
Other Income
|
-- | -- | -- |
|
Profit before Tax
|
-88.06 | -- | 2,174.00 |
|
Provision for Tax
|
17.10 | -- | 469.00 |
|
Profit after Tax (Net Income)
|
-122.57 | -- | 1,714.00 |
|
Minority Interest
|
-- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- |
Liabilities ($ Mln)
| Tilray Brands Inc. Class 2 (TLRY) | Lexaria Bioscience (LEXX) | Cardinal Health (CAH) | |
|---|---|---|---|
|
Shareholder's Funds
|
1,614.33 | -- | -2,883.00 |
|
Minority Interest
|
-- | -- | -- |
|
Non-Current Liabilities
|
374.77 | -- | 16,119.00 |
|
Current Liabilities
|
358.38 | -- | 43,904.00 |
|
Total Liabilities
|
2,328.01 | -- | 57,299.00 |
Assets ($ Mln)
| Tilray Brands Inc. Class 2 (TLRY) | Lexaria Bioscience (LEXX) | Cardinal Health (CAH) | |
|---|---|---|---|
|
Non-Current Assets
|
1,535.88 | -- | 18,546.00 |
|
Current Assets
|
792.13 | -- | 38,753.00 |
|
Total Assets
|
2,328.01 | -- | 57,299.00 |
|
Total Debt*
|
398.40 | -- | 9,948.00 |
|
Net Current Assets
|
433.75 | -- | -- |
Cashflow ($ Mln)
| Tilray Brands Inc. Class 2 (TLRY) | Lexaria Bioscience (LEXX) | Cardinal Health (CAH) | |
|---|---|---|---|
|
Cash From Operating Activities
|
-69.14 | -- | 5,174.00 |
|
Cash Flow from Investing Activities
|
-55.80 | -- | -2,584.00 |
|
Cash from Financing Activities
|
130.99 | -- | -1,602.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- |
Ratios
Profitability Ratios
| Tilray Brands Inc. Class 2 (TLRY) | Lexaria Bioscience (LEXX) | Cardinal Health (CAH) | |
|---|---|---|---|
|
ROCE (%)
|
-5.40 | -- | 25.15 |
|
ROE (%)
|
-6.65 | -- | -60.52 |
|
ROA (%)
|
-4.68 | -- | 3.10 |
|
EBIT Margin (%)
|
-- | -- | -- |
|
Net Margin (%)
|
-13.39 | -- | 0.67 |
|
Cash Profit Margin (%)
|
-- | -- | -- |
Growth Ratios
| Tilray Brands Inc. Class 2 (TLRY) | Lexaria Bioscience (LEXX) | Cardinal Health (CAH) | |
|---|---|---|---|
|
Revenue Growth (%)
|
-0.19 | -- | 0.14 |
|
EBIT Growth (%)
|
-- | -- | -- |
|
Net Profit Growth (%)
|
95.92 | -- | 9.80 |
|
EPS Growth (%)
|
-- | -- | 0.11 |
|
Book Value Growth (%)
|
-- | -- | -- |
Valuation Ratios
| Tilray Brands Inc. Class 2 (TLRY) | Lexaria Bioscience (LEXX) | Cardinal Health (CAH) | |
|---|---|---|---|
|
Price / Earnings
|
-- | -- | 32.85 |
|
Price / Book Value
|
-- | -- | -19.53 |
|
Dividend Yield (%)
|
-- | -- | -- |
|
EV/EBITDA
|
-4.33 | -- | 17.65 |
|
Market Cap ($ Cr)
|
-- | -- | -- |
Solvency Ratios
| Tilray Brands Inc. Class 2 (TLRY) | Lexaria Bioscience (LEXX) | Cardinal Health (CAH) | |
|---|---|---|---|
|
Debt to Equity
|
0.25 | -- | -3.45 |
|
Short term debt to equity ratio
|
0.02 | -- | -0.72 |
|
Current Ratio
|
2.21 | -- | 0.88 |
|
Quick Ratio
|
1.37 | -- | 0.49 |
|
Interest Coverage
|
-1.94 | -- | 7.25 |
Operating Efficiency Ratios
| Tilray Brands Inc. Class 2 (TLRY) | Lexaria Bioscience (LEXX) | Cardinal Health (CAH) | |
|---|---|---|---|
|
Debtors to sales (%)
|
20.66 | -- | 5.43 |
|
Asset Turnover
|
0.35 | -- | 4.61 |
|
Receivable days
|
70.99 | -- | 19.43 |
|
Inventory Days
|
187.61 | -- | 25.49 |
|
Payable days
|
129.76 | -- | 54.53 |
|
Cash Conversion Cycle
|
128.85 | -- | -9.60 |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
